On October 30, 2024 a proposed class action was filed in Vancouver on behalf of all Canadians whose personal information was compromised in the Cencora, Inc. and Innomar Strategies, Inc. privacy ...

Imbrium Therapeutics L.P. ("Imbrium"), a subsidiary of Purdue Pharma L.P. ("Purdue"), today announced the first patient has been randomized and dosed in a Phase 2 clinical study evaluating sunobinop ...